Experts have warned that ‘miracle’ weight loss drugs could cause fractures and weakened bones.
Drugs like Ozempic and Wigovy can reduce body weight by 20%, but studies have shown they also have long-term effects on bone density.
A study published in the American Society for Bone and Mineral Research raised serious concerns about the potential side effects of these treatments.
One study published in the medical journal JAMA evaluated 200 people using the drug and found that bone density in the hips and spine decreased compared to a placebo or exercise alone. did.
This means patients receiving weight loss injections may be at increased risk of osteoporosis, a disease that thins the bones.
Experts have warned that ‘miracle’ weight loss drugs like Ozempic and Wigovy can cause fractures and weakened bones.
A study published in the American Society for Bone and Mineral Research found that people who took the drug had decreased bone density in their hips and spine.
“While the benefits of weight loss are undeniable, evidence also shows a reduction in lean body mass and bone density, which is of particular concern for patients with conditions such as osteoporosis, who are more prone to fractures,” said the founder of the University of London. Dr. Taher Mahmood says: Osteoporosis clinic.
“This data raises concerns for people who are already at high risk of osteoporosis and fractures, such as those with obesity and type 2 diabetes.”
Ozempic and Wegovy are a class of drugs known as GLP-1 agonists that reduce hunger.
Last week, the government announced it would provide the drug to unemployed people.
But experts say giving these shots to thousands of people could increase cases of osteoporosis, which can lead to dangerous fractures and falls.
Dr. Mahmood says it’s important for patients taking GLP-1 drugs to exercise. “The importance of strength training as well as aerobic exercise should be promoted to prevent muscle and bone loss.”
“Tackling obesity is something we have to tackle as a country.
“However, it is essential to combine medical science with education and support to ensure that people taking GLP-1 agonists are aware of the importance of proper nutrition and weight-bearing exercise.”
